HIV-1 Drug Resistance Mutations Among Antiretroviral-Naive HIV-1- Infected Patients in Asia: Results From the TREAT Asia Studies to Evaluate Resistance-Monitoring StudySUNGKANUPARPH, Somnuek; OYOMOPITO, Rebecca; PHANUPHAK, Praphan et al.Clinical infectious diseases. 2011, Vol 52, Num 8, pp 1053-1057, issn 1058-4838, 5 p.Article

Lymphocyte subsets in healthy children from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 studySHEARER, William T; ROSENBLATT, Howard M; YOGEV, Ram et al.Journal of allergy and clinical immunology. 2003, Vol 112, Num 5, pp 973-980, issn 0091-6749, 8 p.Article

Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapyWEINBERG, Adriana; PAHWA, Savita; OYOMOPITO, Rebecca et al.Clinical infectious diseases. 2004, Vol 39, Num 1, pp 107-114, issn 1058-4838, 8 p.Article

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-PacificHAMERS, Raph L; OYOMOPITO, Rebecca; ABDALLAH, Saade et al.International journal of epidemiology. 2012, Vol 41, Num 1, pp 43-54, issn 0300-5771, 12 p.Article

Evaluating Immunologic Response and Clinical Deterioration in Treatment-Naive Patients Initiating First-Line Therapies Infected With HIV―1 CRF01_AE and Subtype BOYOMOPITO, Rebecca A; LI, Patrick C. K; JUN YONG CHOI et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 3, pp 293-300, issn 1525-4135, 8 p.Article